More exposure to phthalates — a type of endocrine-disrupting chemical — were tied to altered metabolism and liver damage in a study presented at the European Society of Endocrinology’s annual meeting. (Daily Mail)
The FDA released a safety communication warning patients and healthcare professionals against using unauthorized and unapproved diabetes management devices like glucose monitors, and insulin pumps and dosing systems.
The Endocrine Society lauded Eli Lilly’s announcement that a generic version of lispro insulin is now available — with a 50% lower price-tag than their Humalog U-100.
Researchers in JAMA reviewed how to best manage preexisting diabetes during pregnancy — recommending a “multidisciplinary team that includes maternal-fetal medicine physicians, endocrinologists, ophthalmologists, and nutritionists.”
A mouse model found that heart changes associated with menopause may occur as early as perimenopause. (Acta Physiologica)